Health Impact Study of Aquatabs in Tamale, Ghana

Centers for Disease Control and Prevention (CDC)

Status: Completed

Conditions: Diarrhea

Treatments: Other: Placebo; Other: Sodium dichloroisocyanurate (NaDCC) tablets

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; Industry

Identifiers

NCT00252928

CDC-NCID-4730

Details and patient eligibility

About

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Enrollment: 240 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Households with at least one child under 5 years old

Exclusion criteria

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Triple Blind

---

240 participants in 2 patient groups, including a placebo group

A

Placebo Comparator group

Description:

Placebo group does not receive Aquatabs.

Treatment:

Other: Placebo

B

Experimental group

Description:

Intervention arms receives Aquatabs.

Treatment:

Other: Sodium dichloroisocyanurate (NaDCC) tablets